0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 267 results.
The global Remicade (Infliximab) and Biosimilar market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4% CAGR...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Remicade (Infliximab) Monoclonal Antibody market size is expected to reach $ 3781.3 million by 2029, rising at a market growth of 5.4%...
Catalog:
GIR
June 2023
Price: USD 4,480.00
Etoricoxib is used to reduce inflammation (swelling) and relieve pain in arthritic conditions such as osteoarthritis, rheumatoid arthritis and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
LPI
February 2023
Price: USD 3,660.00
A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory...
Catalog:
MRRPB5
March 2024
Price: USD 2,900.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast...
Catalog:
LPI
January 2024
Price: USD 3,660.00
The global Remicade (Infliximab) and Biosimilar market size was valued at USD 2623.8 million in 2022 and is forecast to a readjusted size of USD 3781...
Catalog:
GIR
June 2023
Price: USD 3,480.00
Biosimilar drug is medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilar drug...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
The global Systemic Autoimmune Disease Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The global Musculoskeletal Disorders Therapeutics market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
